home.social

#cardiomyopathy — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #cardiomyopathy, aggregated by home.social.

  1. Childhood cancer survivor vowing to live ‘life to the fullest’ after heart transplant

    Chemotherapy helped save Sienna Howkins’s life as a four-year-old, but it damaged her heart so much, she needed…
    #NewsBeep #News #Health #AU #Australia #Cardiomyopathy #Chemotherapy #childhoodcancer #heartdisease #heartrecipient #organdonation #Qld #Queensland #Rhabdomyosarcoma #siennahowkins #Transplant
    newsbeep.com/au/510970/

  2. Childhood cancer survivor vowing to live ‘life to the fullest’ after heart transplant

    Chemotherapy helped save Sienna Howkins’s life as a four-year-old, but it damaged her heart so much, she needed…
    #NewsBeep #News #Health #AU #Australia #Cardiomyopathy #Chemotherapy #childhoodcancer #heartdisease #heartrecipient #organdonation #Qld #Queensland #Rhabdomyosarcoma #siennahowkins #Transplant
    newsbeep.com/au/510970/

  3. A comprehensive longitudinal study reveals that the number of patients diagnosed with #cardiomyopathy in Sweden has more than doubled over the past two decades, with these conditions linked to substantial excess mortality.
    #Medical #Epidemiology #Cardiology #sflorg
    sflorg.com/2026/02/med02032601

  4. A short news story I wrote reporting on a study that found the shape of your #heart can help predict risk for atrial fibrillation.
    The first few paragraphs (most of the story):

    Rounder hearts predict future heart failure, a-fib
    Greater left ventricular sphericity showed 47% greater incidence of #cardiomyopathy

    MAY 2023 -- Not everyone’s heart is quite the same shape and its shape changes over time – but this could help predict who’s at risk for #cardiomyopathy.

    A study in CellPress, where researchers analysed cardiac MRIs of over 30,000 people, found that variations in left ventricle sphericity in normal hearts predicted risk for cardiomyopathy and related outcomes.

    Researchers hypothesized that beyond size and function, the shape of hearts might carry extra details about heart health. To study this, they used data from a large biobank with cardiac imaging data to help analyze variation in cardiac morphology in normal populations.

    They noted “Cardiomyopathies of different etiologies often result in a similar end-stage phenotype of a more round, spherical ventricle. Among individuals with known cardiac disease, increased sphericity of the left ventricle (LV) has been associated with adverse outcomes, including ventricular arrhythmias and death.”

    It also stated that “within the spectrum of normal LV chamber size and systolic function, there exists variation in LV sphericity, and this variation may be a marker of cardiac risk with genetic underpinnings.”

    The researchers turned to artificial intelligence to help analyze 38,897 cardiac MRIs from the U.K. Biobank database. The cohort had undergone cardiac MRIs and had normal LV end-diastolic volume, normal LV end-systolic volume, and normal LV ejection fraction.

    The team looked at LV sphericity and whether it predicted incident cardiomyopathy as well as clinical manifestations such as atrial fibrillation, heart failure, and #cardiac arrest. Other factors were taken into account such as body mass index, pulse rate, #hypertension, diabetes, and prior #myocardial infarction.

    “We found that individuals with spherical hearts were 31% more likely to develop atrial fibrillation and 24% more likely to develop cardiomyopathy,” said Dr. David Ouyang in a press release. He is coauthor of the study and a cardiologist at Cedars Sinai in California....

    The full story is online. Sorry, its password protected. It's accessible, free to #doctors and #pharmacists #myocardial #medicine #MedicalPost #MedMastodon #cardiology @medmastodon

    MY NEWS REPORT: canadianhealthcarenetwork.ca/r

    THE STUDY: cell.com/action/showPdf?pii=S2

  5. A Bioinformatic Approach Based on Systems Biology to Determine the Effects of SARS-CoV-2 Infection in Patients with Hypertrophic Cardiomyopathy
    doi.org/10.1155%2F2022%2F53373